Vitamin D Deficiency: Bone Loss and Vascular Dysfunction
NCT ID: NCT00235586
Last Updated: 2007-09-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2004-04-30
2007-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
FACTORIAL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
10 vit. D deficient subjects take vit. D for 3 months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* One year past last menstrual period
* 20 women with Vitamin D levels \< 15 mg/ml
* 20 women with Vitamin D levels \> 30 mg/ml
Exclusion Criteria
* women receiving medication known to effect vascular compliance, including anti-hypertension medications
* subjects receiving therapy for osteoporosis
* hyperthyroidism
* untreated hypothyroidism
* history of metabolic bone disease
* current or previous use of medications known to accelerate bone loss
* chronic liver disease
* chronic renal disease
* diabetes mellitus
* obesity, BMI \> 24
50 Years
90 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Osteoporosis Foundation
OTHER
University of Kansas
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leland Graves, III, MD
Role: PRINCIPAL_INVESTIGATOR
University of Kansas Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Kansas Medical Center
Kansas City, Kansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9248
Identifier Type: -
Identifier Source: org_study_id